Coronavirus LATEST Updates: Mamata Banerjee asks Centre for 5 4-cr vaccine doses, steady supply of remdesivir msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Pharma companies cut remdesivir injection prices on govt intervention: NPPA
SECTIONS
Last Updated: Apr 17, 2021, 07:22 PM IST
Share
Synopsis
According to the details shared by the NPPA, Cadila Healthcare has reduced the price of its REMDAC (Remdesivir 100 mg) injection to Rs 899 from Rs 2,800 earlier. Similarly, Syngene International has cut the price of its brand RemWin to Rs 2,450 from Rs 3,950 earlier.
Agencies
According to the details shared by the NPPA, Cadila Healthcare has reduced the price of its REMDAC (Remdesivir 100 mg) injection to Rs 899 from Rs 2,800 earlier.
Prices of remdesivir injection have been voluntarily curtailed by various drug companies on the intervention of the government, National Pharmaceutical Pricing Authority (NPPA) said on Saturday.
Remdesivir now at Rs 899; producers cut prices post govt intervention
The National Pharmaceutical Pricing Authority under the Department of Pharmaceuticals declared change in prices for seven brands of Remdesivir injections of potency 100mg per vial
BusinessToday.In | April 17, 2021 | Updated 18:36 IST
Pharmaceutical companies manufacturing the anti-COVID medicine Remdesivir in India have voluntarily slashed prices following government intervention, National Pharmaceutical Pricing Authority (NPPA) under the Department of Pharmaceuticals announced on Saturday. The authority declared change in prices for seven brands of Remdesivir injections of potency 100mg per vial.
According to an office memoradum by NPPA dated April 17, 2021, the prices have been slashed in the range of Rs 1,000 to Rs 2,700. After the price cuts, Cadila Healthcare s Remdac continues to be the cheapest Remdesivir injection at Rs 899. The injection was earlier being sold at Rs 2,800.
Prices of remdesivir injection have been voluntarily curtailed by various drug companies on the intervention of the government, National Pharmaceutical Pricing Authority (NPPA) said on Saturday. Drug companies like Cadila Healthcare, Dr Reddy s Laboratories and Cipla have cut the prices of their respective brands of remdesivir injection (100 mg/vial). The antiviral drug is used in the treatment of Covid-19. Due to the government s intervention, the price of #Remdesivir Injection is now reduced! I am thankful to pharmaceutical companies for joining hands with the Government to fight against Covid-19 Pandemic, Union Minister of State for Chemicals and Fertilisers Mansukh L Mandaviya tweeted.
Govt slashes Remdesivir MRP by half, with retro-effect
Sat, Apr 17 2021 12:51 IST |
3 Views
Mumbai, April 17 : Spelling huge relief for lakhs of Covid-19 patients, the government has slashed the prices of the life-saver Remdesivir injection by nearly 50 per cent, to MRP Rs 2,450 per injection now, according to official sources.
In a missive late on Friday, the Ministry of Chemicals & Fertilisers, Department of Pharmaceuticals, NPPA - Advisor (Costs) N.I. Chowdhury has ordered all pharma companies to comply with the revised norms with immediate and retrospective effect. Based on the Form-V furnished regarding voluntary reduction in Maximum Retail Price (MRP) of Remdesivir, Manufacturers/Marketers of the Remdesivir are hereby directed to implement the revised MRP throughout the distribution chain w.e.f. 15.04.2021, irrespective of the batch numbers, the stern notification said.